World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
39203
World Ranking
11585
National Ranking
622

Research.com Recognitions

  • 2020 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Gynaecology and Paediatrics

Overview

Tanja Fehm is affiliated with Heinrich Heine University Düsseldorf in Germany. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in subfields including Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, and Obstetrics and Gynecology.

The scientist's research topics focus extensively on cancer and related therapeutic approaches. Key areas of study include:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Cancer Genomics and Diagnostics
  • Cancer Cells and Metastasis
  • Cancer Treatment and Pharmacology
  • Endometrial and Cervical Cancer Treatments

Among recent publications associated with this researcher are:

  • "Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial" (2023, The Lancet)
  • "Recent advances in radiotherapy of breast cancer" (2020, Radiation Oncology)
  • "Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial" (2023, The Lancet)
  • "Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial" (2020, The Lancet Oncology)
  • "AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021" (2021, Breast Care)

The researcher frequently collaborates with a number of co-authors, including:

  • Peter A. Fasching (120 co-authored works)
  • Volkmar Müller (116 co-authored works)
  • Wolfgang Janni (114 co-authored works)
  • Andreas Schneeweiß (111 co-authored works)
  • Diana Lüftner (82 co-authored works)

Publications are often found in well-established venues such as:

  • Geburtshilfe und Frauenheilkunde (96 publications)
  • Senologie - Zeitschrift für Mammadiagnostik und -therapie (52 publications)
  • Der Gynäkologe (20 publications)
  • Breast Care (18 publications)
  • Cancer Research (17 publications)

Tanja Fehm's work includes contributions relevant to both clinical oncology and molecular research. Their involvement with clinical trials and evidence-based treatment guidelines reflects an emphasis on translational medicine in oncology, particularly in breast cancer and gynecological malignancies.

In 2020, this scientist was recognized by election to the German National Academy of Sciences Leopoldina in the fields of Gynaecology and Paediatrics.

Best Publications

  • A pooled analysis of bone marrow micrometastasis in breast cancer

    Stephan Braun;Florian D. Vogl;Bjørn Naume;Wolfgang Janni

  • Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

    Thorsten Kuehn;Ingo Bauerfeind;Tanja Fehm;Barbara Fleige

  • Systemic spread is an early step in breast cancer.

    Yves Hüsemann;Jochen B. Geigl;Falk Schubert;Piero Musiani

  • Circulating tumor cells in patients with breast cancer dormancy

    Songdong Meng;Debasish Tripathy;Eugene P. Frenkel;Sanjay Shete

  • Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

    Bahriye Aktas;Mitra Tewes;Tanja Fehm;Siegfried Hauch

  • Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

    François-Clément Bidard;François-Clément Bidard;Dieter Peeters;Tanja Fehm;Franco Nolé

  • Early dissemination seeds metastasis in breast cancer

    Hedayatollah Hosseini;Milan M. S. Obradović;Martin Hoffmann;Kathryn L. Harper

  • Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

    Brigitte Rack;Christian Schindlbeck;Julia Jückstock;Ulrich Andergassen

  • HER-2 gene amplification can be acquired as breast cancer progresses.

    Songdong Meng;Debasish Tripathy;Sanjay Shete;Raheela Ashfaq

  • Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer

    Gunter von Minckwitz;Holger Eidtmann;Mahdi Rezai;Peter A. Fasching

  • Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

    Sabine Riethdorf;Volkmar Müller;Liling Zhang;Thomas Rau

  • HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

    Tanja Fehm;Volkmar Müller;Bahriye Aktas;Wolfgang Janni

  • Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

    Sabine Kasimir-Bauer;Oliver Hoffmann;Diethelm Wallwiener;Rainer Kimmig

  • Effect of Luteinizing Hormone–Releasing Hormone Agonist on Ovarian Function After Modern Adjuvant Breast Cancer Chemotherapy: The GBG 37 ZORO Study

    Bernd Gerber;Gunter von Minckwitz;Heinrich Stehle;Toralf Reimer

  • Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer

    Wolfgang J. Janni;Brigitte Rack;Leon W.M.M. Terstappen;Jean Yves Pierga

  • Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative Study

    Frédéric Amant;Gunter von Minckwitz;Sileny N. Han;Marijke Bontenbal

  • Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.

    Christina S. Schuetz;Michael Bonin;Susan E. Clare;Kay Nieselt

  • Treatment of breast cancer during pregnancy: an observational study

    Sibylle Loibl;Sileny N Han;Gunter von Minckwitz;Marijke Bontenbal

  • MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.

    I. Keklikoglou;C. Koerner;C. Schmidt;J. D. Zhang

  • Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis

    Wolfgang Janni;Florian D. Vogl;Gro Wiedswang;Marit Synnestvedt

Frequent Co-Authors

Peter A. Fasching
Peter A. Fasching University of Erlangen-Nuremberg
Andreas Schneeweiss
Andreas Schneeweiss German Cancer Research Center
Diethelm Wallwiener
Diethelm Wallwiener University of Tübingen
Volkmar Müller
Volkmar Müller Universität Hamburg
Michael Untch
Michael Untch Helios Klinikum Berlin-Buch
Dieter Niederacher
Dieter Niederacher Heinrich Heine University Düsseldorf
Matthias W. Beckmann
Matthias W. Beckmann University of Erlangen-Nuremberg
Klaus Pantel
Klaus Pantel Universität Hamburg
Nadia Harbeck
Nadia Harbeck Ludwig-Maximilians-Universität München
Jens Huober
Jens Huober Kantonsspital St. Gallen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in Medicine doesn't always mean becoming a doctor. Many online degree options pave the way for rewarding roles in healthcare. For those interested in healthcare management, CAHME accredited online healthcare administration programs can help launch a career in hospital administration or healthcare leadership, all via flexible online study.

If you’re a registered nurse aiming to advance your credentials, some online RN to BSN programs no clinicals offer a pathway to complete your bachelor’s degree without additional hands-on clinical requirements. This makes career progression more accessible, even with a busy work schedule.

For those seeking the highest levels of practice and leadership, doctorate-level nursing programs are also available online. You can accelerate your education with short DNP programs or find options that balance rigor and flexibility among the easiest DNP programs. These routes are ideal for advancing in clinical practice, administration, or educational roles.

Whether you want to move into administration, improve patient outcomes, or lead teams, these online degrees offer multiple paths to achieve your healthcare career goals while maintaining flexibility.

Best Scientists Citing Tanja Fehm

Trending Scientists